Related Experiment Video
Updated: Mar 15, 2026
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Clinical Approach to the Care of Patients With Recurrent Differentiated Thyroid Cancer: A Focus on Papillary Thyroid
Alejandro Roman-Gonzalez1, Alvaro Sanabria2, Sarimar Agosto-Salgado3
1Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia; Department of Endocrinology, Hospital San Juan de Dios Rionegro, Rionegro, Colombia; Department of Head & Neck Surgery, CEXCA: Centro de Excelencia en Cirugía de Cabeza y Cuello, Medellín, Colombia.
Objective:
To provide a clinically oriented framework for the evaluation and management of recurrent papillary thyroid carcinoma (PTC), integrating updated risk stratification and contemporary therapeutic strategies.
Methods:
A narrative review of recent evidence, including the 2025 American Thyroid Association (ATA) recommendations, was conducted, focusing on risk stratification models, diagnostic pathways, and therapeutic approaches for recurrent and metastatic disease.
Results:
Recurrent PTC represents a heterogeneous clinical entity that requires individualized management. The 2025 ATA guidelines introduce a four-tier recurrence risk model and the DATA framework (Diagnosis, Assessment, Treatment, and Assessment of response), enabling structured clinical decision-making. Management strategies range from active surveillance for low-volume disease to locoregional therapies such as surgery and image-guided ablation in selected cases. In advanced or progressive disease, systemic targeted therapies, ideally guided by molecular profiling, play a central role. Integration of clinical, pathological, and molecular factors is essential to optimize treatment selection and balance disease control with treatment-related morbidity.
Conclusions:
Management of recurrent PTC requires a dynamic, risk-adapted, and multidisciplinary approach. Implementation of the ATA 2025 framework, combined with molecularly informed therapeutic strategies, allows personalized care and may improve long-term outcomes in both locoregional and metastatic disease.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
02:56Treatment Resistant Cancers
01:22Myocarditis IV: Nursing Management
01:16Kidney Transplant III: Nursing Management
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...